DE69806353D1 - Pyrrolo[3,2-c]chinolin-derivate, die eine haloalkoxy-gruppe enthalten und ihre pharmazeutisch verträglichen salze - Google Patents

Pyrrolo[3,2-c]chinolin-derivate, die eine haloalkoxy-gruppe enthalten und ihre pharmazeutisch verträglichen salze

Info

Publication number
DE69806353D1
DE69806353D1 DE69806353T DE69806353T DE69806353D1 DE 69806353 D1 DE69806353 D1 DE 69806353D1 DE 69806353 T DE69806353 T DE 69806353T DE 69806353 T DE69806353 T DE 69806353T DE 69806353 D1 DE69806353 D1 DE 69806353D1
Authority
DE
Germany
Prior art keywords
pyrrolo
haloalkoxy group
derivatives containing
compatible salts
pharmaceutical compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69806353T
Other languages
English (en)
Other versions
DE69806353T2 (de
Inventor
Joong-Kwon Choi
Sung-Soo Kim
Eul-Kyun Yum
Seung-Kyu Kang
Yea-Kang Yoo
Hyae-Gyeong Cheon
Hyo-Jung Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Chemical Technology KRICT
Original Assignee
Korea Research Institute of Chemical Technology KRICT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Research Institute of Chemical Technology KRICT filed Critical Korea Research Institute of Chemical Technology KRICT
Application granted granted Critical
Publication of DE69806353D1 publication Critical patent/DE69806353D1/de
Publication of DE69806353T2 publication Critical patent/DE69806353T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69806353T 1997-08-13 1998-01-08 Pyrrolo[3,2-c]chinolin-derivate, die eine haloalkoxy-gruppe enthalten und ihre pharmazeutisch verträglichen salze Expired - Fee Related DE69806353T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019970038512A KR100251522B1 (ko) 1997-08-13 1997-08-13 할로알콕시기를 함유하는 피롤[3,2-c]퀴놀린 유도체 및 약학적으로 허용되는 그의 염
PCT/KR1998/000001 WO1999009029A1 (en) 1997-08-13 1998-01-08 PYRROLO[3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

Publications (2)

Publication Number Publication Date
DE69806353D1 true DE69806353D1 (de) 2002-08-08
DE69806353T2 DE69806353T2 (de) 2002-10-31

Family

ID=19517351

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69806353T Expired - Fee Related DE69806353T2 (de) 1997-08-13 1998-01-08 Pyrrolo[3,2-c]chinolin-derivate, die eine haloalkoxy-gruppe enthalten und ihre pharmazeutisch verträglichen salze

Country Status (7)

Country Link
US (1) US6011044A (de)
EP (1) EP0966466B1 (de)
JP (1) JP3215850B2 (de)
KR (1) KR100251522B1 (de)
CA (1) CA2268166C (de)
DE (1) DE69806353T2 (de)
WO (1) WO1999009029A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001696A1 (en) * 1998-07-02 2000-01-13 Korea Research Institute Of Chemical Technology 3-ALKYLPYRROLO[3,2-c]QUINOLINE DERIVATIVES
CA2461142A1 (en) * 2001-09-24 2003-04-03 Bayer Pharmaceuticals Corporation Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
DE10220459A1 (de) * 2002-05-07 2003-11-27 Byk Gulden Lomberg Chem Fab Neue Kombination zur Behandlung von Atemwegserkrankungen
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
EP1682133A1 (de) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo-1,2-a-pyridin-derivate zur behandlung von beschwerdefreiem gastroösophagealem reflux
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
GB0709513D0 (en) * 2007-05-17 2007-06-27 Helperby Therapeutics Ltd Topical formulations
AU2009276082B2 (en) 2008-07-29 2014-01-23 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it
KR101254038B1 (ko) * 2011-01-12 2013-04-12 한국화학연구원 퀴놀린올 화합물을 유효성분으로 포함하는 항진균 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717644D0 (en) * 1987-07-24 1987-09-03 Smithkline Beckman Intercredit Compounds
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
KR100187475B1 (ko) * 1996-05-17 1999-05-01 이서봉 1-아릴-4-옥소 피롤로(3,2-c)퀴놀린 유도체의 제조방법

Also Published As

Publication number Publication date
KR19990016074A (ko) 1999-03-05
CA2268166C (en) 2003-05-06
JP3215850B2 (ja) 2001-10-09
DE69806353T2 (de) 2002-10-31
CA2268166A1 (en) 1999-02-25
KR100251522B1 (ko) 2000-08-01
JP2000504352A (ja) 2000-04-11
US6011044A (en) 2000-01-04
WO1999009029A1 (en) 1999-02-25
EP0966466B1 (de) 2002-07-03
EP0966466A1 (de) 1999-12-29

Similar Documents

Publication Publication Date Title
DE69738460D1 (de) Pharmazeutische Zusammensetzung mit verzögerter Freisetzung, die wasserunlösliche Komplexverbindungen enthalten
DE69016125D1 (de) Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
FR2650964B1 (fr) Catalyseur d'hydrogenation a base de compose du titane et procede d'hydrogenation l'utilisant
DE69638348D1 (de) Arzneizubereitung enthaltend Irbesartan und ein Diuretikum
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
BR9600148A (pt) Quinazolinonas 2,8-dissubstituídas processo para sua preparação medicamentos e uso
ATE164843T1 (de) Naphthalinderivate, ihre herstellungsverfahren und zwischenprodukte dafür, und diese enthaltende pharmazeutische zusammensetzungen
HUP9901243A3 (en) Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
IL130297A0 (en) Sulphonamide derivatives process for their preparation and their use as medicaments
DE60032940D1 (de) Neue verfahren und zubereitungen die opioiden und deren antagonisten enthalten
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE252542T1 (de) Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen,die diese enthalten
ATE222897T1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen,die sie enthalten
HUP9801394A3 (en) 6-phenyl-pyrazolo[3,4-d]pyrimidin-4-one derivatives and pharmaceutical compositions containing them
DE69326569D1 (de) Sterinderivate, Verfahren zu ihrer Herstellung und dermatologische Präparate
HUP9802807A3 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives, their use, production thereof and medicaments containing the same
DE69806353D1 (de) Pyrrolo[3,2-c]chinolin-derivate, die eine haloalkoxy-gruppe enthalten und ihre pharmazeutisch verträglichen salze
AR013264A1 (es) Derivados de 4-oxo-3,5-dihidro-4h-piridazino[4,5-b]indol-1-acetamida, medicamento y composicinn farmaceutica
DE69818516D1 (de) Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten
DE69006676D1 (de) Tripeptidverbindungen und ihre pharmazeutische Anwendung als Immunmodulatoren.
ATE289595T1 (de) Neue pyrimidin-2,4,6-trion-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten
AU5107696A (en) Cyclohexylamino and cyclohexylalkoxy nitrogen heterocycles, methods of preparing them and their use as pest-control agents and fungicides
DE69722433D1 (de) Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten
GB9518553D0 (en) New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
RU93047049A (ru) Новые производные фосфолипидов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee